Business Standard

Monday, January 06, 2025 | 09:39 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Moderna gets further $472 mn US award for Covid-19 vaccine development

The drug maker said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of Moderna's vaccine candidate

covid, coronavirus, vaccine, drug, pharma
Premium

The drug maker said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of Moderna's vaccine candidate.

Reuters
Moderna Inc said on Sunday it has received an additional $472 million from the US government's Biomedical Advanced Research and Development Authority (BARDA) to support development of its novel coronavirus vaccine.

The drug maker said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of Moderna's vaccine candidate.


What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in